04:25 PM EST, 12/13/2024 (MT Newswires) -- West Pharmaceutical Services ( WST ) late Friday said in a regulatory filing it authorized the repurchase of up to 550,000 of its common shares from time to time.

The new stock buyback program is expected to run through Dec. 31, 2025, and will replace the company's existing program scheduled to expire at the end of the current year.